Both in Pharmaceuticals
TransCode Therapeutics vs Adicet Bio
Over the past year RNAZ returned −83.2% and ACET returned −71.9%; their daily moves had a correlation of 0.05.
RNAZ −83.2% ACET −71.9%Growth of $1, one year, split-adjusted
| Metric | RNAZ | ACET |
|---|---|---|
| Price | $1.60 | $3.10 |
| Market cap | $27.1M | $29.0M |
| Today | +1.91% | −2.21% |
| 1 month | −10.1% | −50.4% |
| 6 months | −78.7% | −63.7% |
| Year to date | −76.6% | −63.2% |
| 1 year | — | −73.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.7M | $117.4M |
| Dividend yield | — | — |
| Volatility (60d) | 72.5% | 96.7% |
| Short % of float | 8.1% | 6.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).